Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis

NEXT STORY
Erasca is Named One of Fierce Biotech’s “Fierce 15” Biotechnology Companies of 2021
PREV STORY
Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)

author_avatar
NASDAQ Market News

The North America immunochemistry market is expected to reach US$ 1,536.87 Mn in 2027 from US$ 806.34 Mn in 2018

author_avatar
NASDAQ Market News

Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting

BERKELEY, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

author_avatar
NASDAQ Market News